Press

This talk by CEO Christina K. Lopes explores how our learnings from transforming canine cancer can inform how to transform cancer in humans- impacting both sides of the leash.

Similarities between human and canine cancers have led to an influx of interest and funding in comparative oncology

There are many successes of precision medicine implementation in human oncology and it is therefore integrated into human cancer management. It is increasingly integrated into canine cancer management, with early evidence of its success.

A study from researchers at Tufts University, Broad Institute of MIT and Harvard, and FidoCure by One Health Company illuminates the complex landscape between genetics and disease outcomes for a common and aggressive cancer that affects millions of dogs.

Naturally occurring canine cancers have remarkable similarities to their human counterparts. To better understand these similarities, we investigated 671 client-owned dogs from 96 breeds with 23 common tumor types.

Despite a growing number of targeted cancer treatments in development each year, few are able to reach cancer patients due to the rate at which evidence is generated from human clinical trials

Compelling genetic data, increased funding and growing collaborations in the past decade are pushing forward development of cancer drugs for both canines and humans

Despite a growing number of targeted cancer treatments in development each year, few are able to reach cancer patients due to the rate at which evidence is generated from human clinical trials

Researchers from Stanford AI Health and One Health, the world’s first translational canine cancer care company, published the results from the largest-ever genomic study of canine cancer which revealed a promising path for enhanced human cancer treatments.

Every year, thousands of pets develop tumors very similar to those found in people. Find drugs that work for canines, and human treatments should follow.

New findings have revealed previously undetected genetic similarities between dog and human cancers, a discovery that could be used to accelerate cancer R&D for both species. 

Research reveals for the first time that humans and dogs share many of the same genetic causes of cancer. 

Dogs and humans share 18 cancer mutation ‘hotspots’, Harvard study shows.

New research reveals previously unknown similarities in the way man’s best friend shares man’s worst struggle

The largest investigation into how pet dogs respond to cancer drugs promises to reveal new ways of treating the disease in humans.

Special CBS News Philadelphia segment featuring Dr. Dorothy Girimonte of  Saint Francis Veterinary Center of South Jersey, a Thrive Pet Healthcare hospital. 

Compelling genetic data, increased funding and growing collaborations in the past decade are pushing forward development of cancer drugs for both canines and humans

The One Health Company CEO and co-founder Christina Kelly Lopes joins ‘Mornings with Maria’ to discuss canine cancer and the various ways FidoCure is using pet DNA to generate proper diagnoses.  

Christina shared valuable insights into how tumor profiling and targeted therapies are making a significant impact in veterinary medicine, mirroring advances in human healthcare.